Amanote Research

Amanote Research

    RegisterSign In

Maximum Benefit of Chemotherapy for Osteosarcoma Achieved—what Are the Next Steps?

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(16)30270-4
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

October 1, 2016

Authors
Eugenie Kleinerman
Publisher

Elsevier BV


Related search

Toward Ending Hepatitis C Virus Infection: What Are the Next Steps?

CMAJ
Medicine
2017English

Forest Landscape Ecology and Global Change: What Are the Next Steps?

2014English

Viewpoint: HIV/AIDS and the Health Workforce Crisis: What Are the Next Steps?

Tropical Medicine and International Health
EnvironmentalParasitologyInfectious DiseasesPublic HealthOccupational Health
2005English

What Is the Next Tool to Replace the Cost-Benefit Analysis?

Nippon Suisan Gakkaishi
Aquatic Science
2007English

Asthma: 1987-2007. What Have We Achieved and What Are the Persisting Challenges?

Primary Care Respiratory Journal
2007English

DNA Damage Response as Biomarkers Informing a Precision Medicine Approach to Bladder Cancer: What Are the Next Steps?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2018English

Next Steps for Pharmaceutical Nanotechnology

Journal of Pharmaceutical Innovation
Drug DiscoveryPharmaceutical Science
2010English

What Are You Ng Next September?

British Dental Journal
Dentistry
2019English

Evaluation of Adjuvant Chemotherapy for Osteosarcoma.

Orthopedics & Traumatology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy